Free Trial
NYSEARCA:BOUT

Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News

$37.40 +0.07 (+0.19%)
Closing price 07/18/2025 04:10 PM Eastern
Extended Trading
$37.45 +0.05 (+0.13%)
As of 07/18/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Key Stats

Today's Range
$37.40
$37.40
50-Day Range
$34.42
$37.40
52-Week Range
$31.08
$42.41
Volume
96 shs
Average Volume
2,259 shs
Market Capitalization
$11.22 million
Assets Under Management
$11.22 million
Dividend Yield
0.61%
Net Expense Ratio
0.85%
Aggregate Rating
Moderate Buy

ETF Overview

Innovator IBD Breakout Opportunities ETF Expenses

TypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.80%0.47%0.56%0.51%0.53%
Other Expenses0.05%0.49%0.56%0.59%0.56%
Total Expense0.85%0.67%0.76%0.74%0.73%
Fee Waiver0.00%-0.59%-0.66%-0.71%-0.63%
Net Expense0.85%0.53%0.63%0.58%0.60%
Receive BOUT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter.

BOUT ETF News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
See More Headlines

BOUT ETF - Frequently Asked Questions

Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 at the beginning of the year. Since then, BOUT shares have decreased by 4.3% and is now trading at $37.40.

Innovator IBD Breakout Opportunities ETF's top institutional investors include Nova Wealth Management Inc. (1.66%).

Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET).

Fund Details

Issuer
Innovator Capital Management
Fund Name
Innovator IBD Breakout Opportunities ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BOUT
Inception Date
9/13/2018
Fund Manager
Dustin Lewellyn, Ernesto Tong, Anand Desai
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
IBD Breakout Stocks Index
Category
Broad Equity
Focus
Strategy
Development Level
Developed Markets
Region
North America
Number of Holdings
141

Fund Statistics

Assets Under Management
$11.22 million
Average Daily Volume
$965.00
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Innovator Capital Management, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
100 shs

Miscellaneous

Beta
0.98
Creation Unit
50,000
Creation Fee
$250.00
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Top 10 BOUT Holdings

BOUT Sector Exposure

BOUT Industry Exposure


This page (NYSEARCA:BOUT) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners